Where to buy
Capital Increase — $100 million for Market Development in China
In January 2018, HSIESH BIOTECH (HANGZHOU) CO. LTD. has successfully completed the capital increase by $100 million. HSIEHS BIOTECH (SINGAPORE) PTE. LTD. holds a 100% stake in the Hangzhou company.
2018 Chinese New Year Holiday Notice
Wishing You A Happy & Prosperous Chinese New Year!
Get Exclusive Promotion with Standard Chartered Cards
HSIEHS BIOTECH has been granted another patent from Intellectual Property Office of Singapore
Great News! Golden Lypres® has obtained patents granted by US and South Korea
Launching of Golden Lypres® on Suncity VIP Clubs’E-Mall Shopping Platform in Macau
Golden Lypres® has been honored with the “Gold Product for Public Health Award” 2017
Hsiehs Biotech is honored to receive a gold trophy for having its product, Golden Lypres®, being selected as one of the four gold winners of Gold Product for Public Health Award 2017.
Good News —— Ten Million (US dollars) Product Liability Insurance, a Protection for You!
Good News! Golden Lypres® has obtained another international patent granted by South Korea.
Price Adjustment Notice（Singapore）